[1]李晓丹,张百珂,贾雍,等.折叠式人工玻璃体球囊植入在玻璃体视网膜疾病治疗中的应用[J].眼科新进展,2020,40(7):670-673.[doi:10.13389/j.cnki.rao.2020.0154]
　LI Xiaodan,ZHANG Baike,JIA Yong,et al.The clinical effect of foldable capsular vitreous body implantation in the treatment of vitreoretinal diseases[J].Recent Advances in Ophthalmology,2020,40(7):670-673.[doi:10.13389/j.cnki.rao.2020.0154]
点击复制

折叠式人工玻璃体球囊植入在玻璃体视网膜疾病治疗中的应用/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年7期
页码:
670-673
栏目:
应用研究
出版日期:
2020-07-05

文章信息/Info

Title:
The clinical effect of foldable capsular vitreous body implantation in the treatment of vitreoretinal diseases
作者:
李晓丹; 张百珂; 贾雍; 郭丽莎; 田学敏
450000　河南省郑州市，中国人民解放军联勤保障部队第九八八医院
Author(s):
LI Xiaodan;  ZHANG Baike; JIA Yong;  GUO Lisha;  TIAN Xuemin
Department of Ophthalmolgy, 988 Hospital of PLA, Zhengzhou 450000, Henan Province, China
关键词:
玻璃体视网膜疾病; 玻璃体切割术; 折叠式人工玻璃体球囊
Keywords:
vitreoretinal diseases;  vitrectomy;  foldable capsular vitreous body
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2020.0154
文献标志码:
A
摘要:
目的　探讨折叠式人工玻璃体球囊(foldable capsular vitreous body，FCVB)治疗玻璃体视网膜疾病的临床效果。方法　回顾性分析2017年9月至2019年1月行玻璃体切割联合FCBV植入术的43例（43眼）患者的临床资料。术后随访6个月，观察术后视力、眼压、视网膜复位情况和FCBV状态。结果　术后6个月，43例视力无明显变化，手术前后差异无统计学意义（P=1.000）。术后6个月，4例眼压降低，39例眼压正常，手术前后差异有统计学意义（P=0.002）。眼底照相、B超、OCT检查结果显示：所有患者视网膜复位良好，FCVB在玻璃体内均匀地支撑视网膜。双眼外观对称，眼球活动正常。随访期末1例眼球轻微萎缩、1例出现角膜血管化，经治疗后情况好转。结论　在患者6个月的植入期内，FCVB是安全、有效的玻璃体替代物，可以维持眼球形态和稳定眼压。
Abstract:
Objective　To explore the clinical effect of foldable capsular vitreous body (FCVB) implantation in the treatment of vitreoretinal diseases. Methods　The clinical data of 43 patients (43 eyes) with FCVB implantation from September 2017 to January 2019 were analyzed retrospectively. All patients underwent vitrectomy combined with FCVB implantation. After surgery, visual acuity, intraocular pressure, retinal reattachment and FCVB status were observed in the follow-up of 6 months. Results　At 6 months after operation, 43 patients had no significant difference in visual acuity compared with that before surgery (P=1.000). Intraocular pressure decreased in 4 patients and was normal in 39 patients. There was significant difference of intraocular pressure before and after operation (P=0.002). Fundus photography, ultrasound and OCT showed that all patients’ retinal reattachment was well and retina was supported evenly by FCVB in the vitreous cavity. The eyes were symmetrical in appearance and normal in movement. At the end of follow-up, 1 patient had atrophy of eyeball, and 1 patient had corneal vascularization, and both improved after treatment. Conclusion　FCVB is an effective and safe substitute of vitreous, which can maintain ocular morphology and stabilize intraocular pressure in the 6 months follow-up.

参考文献/References:

［1］　MARIACHER S，SZURMAN P.Artificial vitreous body:Strategies for vitreous body substitutes［J］.Ophthalmologe,2015,112(7):572-579.
［2］　GAO Q Y,FU Y,HUI Y N.Vitreous substitutes:challenges and directions［J］.Int J Ophthalmol,2015,8(3):437-440.
［3］　BARTH H，CRAFOORD S，ANDRE ASSON S，GHOSH F.A cross-linked hyaluronic acid hydrogel (Healaflow(?)) as a novel vitreous substitute［J］.Graefes Arch Clin Exp Ophthalmol,2016,254(4):697-703.
［4］　GAO Q，MOU S，GE J，TO C H，HUI Y，LIU A,et al.A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve［J］.Eye (Lond),2008,22(3):461-468.
［5］　WANG P，GAO Q Y，JIANG Z，LIN J X，LIU Y Q，CHEN J J,et al.Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes［J］.Clin Experiment Ophthalmol，2012,40(1):e67-75.
［6］　LIU Y Q，KE Q C，CHEN J J，WANG Z C，XIE Z Y，JIANG Z X,et al.Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body［J］.Invest Ophthalmol Vis Sci,2010,51(3):1636-1642.
［7］　CHEN H，FENG S F，LIU Y Q，HUANG Z，SUN X Y，ZHOU L,et al.Functional evaluation of a novel vitreous substitute using polyethylene glycol sols injected into a foldable capsular vitreous body［J］.J Biomed Mater Res A,2013,101(9):2538-2547.
［8］　叶燕花,谭素芬,吴素虹.人工玻璃体植入治疗严重眼外伤视网膜脱离患者的护理［J］.现代医院,2013,13(1):75-76.
YE Y H,TAN S F,WU S H.Care of artificial vitreous implanted in the treatment of patients with severe ocular trauma retinal detachment［J］.Modern Hosp,2013,13(1):75-76.
［9］　GAO Q，CHEN X，GE J，LIU Y J，JIANG Z X，LIN Z,et al.Refractive shifts in four selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou-Brennan schematic eyes［J］.Invest Ophthalmol Vis Sci,2009,50(7):3529-3534.
［10］　LIN X F，GE J，GAO Q Y，WANG Z F，LONG C D，HE L W，et al.Evaluation of the flexibility,efficacy,and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment［J］.Invest Ophthalmol Vis Sci,2011,52(1):374-381.
［11］　LIN X F，SUN X Y，WANG Z F，JIANG Z X，LIU Y Q，WANG P J，et al.Three-year efficacy and safety of a silicone oil-filled foldable-capsular-vitreous-body in three cases of severe retinal detachment［J］.Transl Vis Sci Technol,2016,5(1):1-8.
［12］　张贵森,巩慧,惠延年,刘磊,任凤梅.折叠式人工玻璃体球囊植入的初步临床实践［J］.国际眼科杂志,2018,18(3):578-580.
ZHANG G S,GONG H,HUI Y N,LIU L,REN F M.Preliminary clinical pract ice in im plant at ion of foldable capsular vitreous body［J］.Int Eye Sci,2018,18(3):578-580.
［13］　YANG W,YUAN Y G,ZONG Y,HUANG Z,MAI S Y,LI Y J,et al.Preliminary study on retinal vascular and Oxygen-related changes after long-term silicone oil and foldable capsular vitreous body tamponade［J］.Sci Rep,2014,4:5272.
［14］　LIN X F，WANG Z F，JIANG Z X，LONG C D，LIU Y Q，WANG P J，et al.Preliminary efficacy and safety of a silicone oil-filled foldable capsular vitreous body in the treatment of severe retinal detachment［J］.Retina,2012,32(4):729-741.
［15］　MILLER J B，PAPAKOSTAS T D，VAWAS D G.Complications of emulsified silicone oil after retinal detachment repair［J］.Semin Ophthalmol,2014,29(5-6):312-318.
［16］　TOKLU Y，CAKMAK H B，ERGUN S B，YORGUN M A，SIMSEK S.Time course of silicone oil emulsification［J］.Retina,2012,32:2039-2044.
［17］　李博,孙琳.玻璃体手术治疗儿童外伤性眼内炎临床分析［J］.河南科技大学学报(医学版),2017,35(2):113-117.
LI B，SUN L.Efficacy of vitrectomy for traumatic endophthalmitis of children［J］.J Henan Univ Sci Tech,2017,35(2):113-117.
［18］　忻双华,王惠云,陆勤康,赵娜.玻璃体切除联合硅油填充治疗儿童外伤性感染性眼内炎［J］.中华医院感染学杂志,2012,22(3):528-529.
XIN S H,WANG H Y,LU Q K,ZHAO N.Vitrectomy and silicone oil tamponade treatment of traumatic infectious endophthalmitis in children［J］.Chin J Nosocomiol,2012,22(3):528-529.
［19］　ZHENG H H,WANG Z M,WANG P J,LIU Y Q,JIANG Z X,GAO Q Y.Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo［J］.Graefes Arch Clin Exp Ophthalmol,2012,250（5）:751-759.

相似文献/References:

[1]董敬远 刘瑶 吴晓艳.玻璃体切割联合白内障手术治疗增生性糖尿病视网膜病变[J].眼科新进展,2012,32(5):000.
[2]张楚 邹玉平 邹秀兰 徐哲 王泳.内窥镜引导玻璃体视网膜手术治疗伴有角膜混浊的外伤性视网膜脱离[J].眼科新进展,2012,32(6):000.
[3]刘刚 马英慧 贾万程.玻璃体切割术联合视网膜光凝或内界膜剥除术治疗黄斑裂孔性视网膜脱离的疗效分析[J].眼科新进展,2012,32(7):000.
[4]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[5]刘敬花 李松峰 卢海.23G微创玻璃体切割术在增生性糖尿病视网膜病变治疗中的应用[J].眼科新进展,2012,32(11):000.
[6]王蕊 王兴利 王一.玻璃体切割术治疗球内金属异物并发眼内炎的玻璃体腔填充物的选择[J].眼科新进展,2012,32(11):000.
[7]杨铮 陈彬川 周瑞雅.玻璃体手术后高眼压及其处理[J].眼科新进展,2012,32(11):000.
[8]陈吉婷 李学喜 王志军.两种手术方式取出眼后段磁性异物的对比研究[J].眼科新进展,2012,32(11):000.
[9]张保松.复杂开放性眼外伤手术疗效及其相关影响因素分析[J].眼科新进展,2012,32(12):000.
[10]杜新华 吴强 宋蓓雯 陈永东 陈颖 罗兰.非外伤性玻璃体积血的发病原因及疗效分析[J].眼科新进展,2013,33(1):000.
[11]荣华 张美萍 陈建梅 崔红平.微切口白内障超声乳化联合微创玻璃体切割手术治疗并发白内障的玻璃体视网膜疾病[J].眼科新进展,2013,33(11):000.

备注/Memo

备注/Memo:
N/A
更新日期/Last Update: 2020-07-05